A good news for Chronic Spinal Cord Injury (SCI) cure is coming from Stem Cells Inc.
“StemCells, Inc.(Nasdaq:STEM) today announced that the twelve month data from the first patient cohort in the Company’s Phase I/II clinical trial of its proprietary HuCNS-SC® product candidate (purified human neural stem cells) for chronic spinal cord injury continued to demonstrate a favorable safety profile, and showed that the considerable gains in sensory function observed in two of the three patients at the six-month assessment have persisted.”(1)
This is a first step but it is showing all of us that our dreams for a cure may become a reality!
“While we need to be cautious when interpreting data from a small, uncontrolled trial, to our knowledge, this is the first time a patient with a complete spinal cord injury has been converted to a patient with an incomplete injury following transplantation of neural stem cells. We are encouraged that the cells appear to convey clinical benefit in such severely injured patients.” (2)